About this course

Immune checkpoint inhibitors help the immune system to destroy cancer cells. This type of immunotherapy works differently from chemotherapy and causes different kinds of side effects, called immune-related adverse events.

Expert Faculty

Bernardo L Rapoport MD
Specialist Physician and Medical Oncologist-in-Charge, The Medical Oncology Centre of Rosebank, Saxonwold, Johannesburg; and Department of Immunology, Faculty of Health Sciences, University of Pretoria, South Africa 

Helen Westman RN MN (Oncology)
Lung Cancer Nurse Coordinator, Cancer and Palliative Care Network; Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, New South Wales, Australia

CPD Accreditation
On successful completion of this course South African registered medical professionals (HPCSA) are able to receive 1 CPD point - Level 1 Clinical.

Course accreditation number: MDB015/121/01/2022

An independent program provided as a service to medicine by MSDMSD (Pty) Ltd (Reg. No. 1996/003791/07) 117-16th Road, Private Bag 3, Halfway House, 1685, South Africa. Tel: +27(0)11655-3000. www.msd.co.za. Copyright ©2021. Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. All rights reserved. ZA-KEY-00312. Exp. Date: 28/05/2023

Learning objectives

This concise interactive program is designed to help primary care providers:

  • recognize the irAEs associated with ICI treatment

  • support patients undergoing ICI treatment

  • provide prompt referral for specialist care when appropriate